Lower socioeconomic status was linked with worse eye structure and function at initial presentation in patients undergoing ...

The consensus rating for Ocugen is Buy, derived from 4 analyst ratings. An average one-year price target of $7.25 implies a ...

Authorities said William August Gilbert, 37, was previously convicted of "repeated acts of sexual assault" against a child in ...

Topcon Healthcare acquired RetInSight, an Austria-based company that develops AI-driven software for eye care professionals, ...

Machine learning algorithms enhance retinopathy of prematurity screening using smartphone images, expanding access in ...

Almanza, 26, of Mount Joy, was sentenced to 33 months to 8 years in prison after pleading guilty to multiple charges in ...

In a new National Institutes of Health-funded study led by scientists at the Wilmer Eye Institute, Johns Hopkins Medicine ...

The JADE study will be evaluating BI 1584862, an investigational oral compound that targets inflammation and preserves ...

Unifeye Vision Partners, an ASC operator in the ophthalmology sector, received a growth capital investment and added an ophthalmology practice and surgery center in Texas.  The company partnered with ...

Subcutaneous administration generally safe and well-tolerated across multiple doses>80% reduction in anti-VEGF intravitreal injection burden in wet AMD and DME study eyes and >75% total reduction in ...

Alkeus Pharmaceuticals reveals promising Phase 2 SAGA study results, showing gildeuretinol slows vision decline in geographic ...